UPSC Margin
NotesTestsDaily CACSAT
UPSC Margin

Analytical concept notes, daily current affairs, and mock tests for serious UPSC aspirants.

Learn

  • Notes
  • Daily Current Affairs
  • Mock Tests
  • CSAT
  • Strategy Guide

Resources

  • About
  • Pricing
  • Blog
  • Contact
  • RSS Feed

Support

  • Help & FAQ
  • Privacy Policy
  • Terms of Use
  • Telegram Community

© 2026 UPSC Margin. All rights reserved.

Operated by Satyam Raj · hello@upscmargin.com

Back to Notes
EconomyFree till Sep 9

Intellectual Property Rights in India: Patents, Copyrights, Trademarks

July 19, 2026

TOPIC CLASSIFICATION

Subject: Indian Economy — Intellectual Property Rights
Sub-topic: Patents, Copyrights, Trademarks, Geographical Indications, IPR Regime
Mains GS Paper-III: IPR — challenges, policy, TRIPS, and innovation.


EXAMINER REASONING

IPR is a multidisciplinary topic — connecting economy, law, science & technology, and international relations. Prelims tests: types of IP (Patents, Copyright, Trademark, GI, Industrial Design, Plant Variety, Semiconductor IC layout), the Acts (Patents Act 1970, Copyright Act 1957, Trade Marks Act 1999), and key terms (compulsory licensing, prior art, fair use). Mains demands: (a) India's compliance with TRIPS Agreement, (b) the Patent (Amendment) Act 2005 — product patent regime for pharmaceuticals, (c) compulsory licensing (Natco v. Bayer, 2012), (d) GI tag impact on rural economy. The compulsory licensing + access to medicines debate is the examiner's favourite pressure point.


Core Concept

Types of Intellectual Property Rights (IPR):

TypeProtectsProtecting ActDuration
PatentInventions (product/process)Patents Act, 1970 (amended 1999, 2002, 2005)20 years
CopyrightLiterary, artistic, musical worksCopyright Act, 1957 (amended 2012)Life + 60 years
TrademarkBrand names, logos, symbolsTrade Marks Act, 1999

Read Next

More in Economy

Agriculture Marketing: APMC, eNAM, and Farm Reforms

Banking Sector Reforms: NPAs, Consolidation, and Financial Inclusion

India's banking sector has undergone a transformation — from the 1991 Narasimham reforms to the 2016 IBC, PSB consolidation, and the Jan Dhan-Aadhaar-Mobile (JAM) trinity for financial inclusion. This note covers NPA resolution mechanisms, bank mergers, the role of the RBI, and the remaining challenges of governance and capitalisation.

Competition Law: CCI, Anti-Trust, and Market Regulation

10 years (renewable)
GIGeographical origin productsGI of Goods Act, 199910 years (renewable)
Industrial DesignShape/configuration/patternDesigns Act, 200010+5 years
Plant VarietyNew plant varietiesPPV&FR Act, 200115-18 years
Semiconductor IC LayoutIntegrated circuit layoutSICLD Act, 200010 years

Key Features of Indian Patent Regime:

  • Transition from process to product patents (2005 amendment, TRIPS compliance)
  • Section 3(d): Prevents evergreening of patents — new forms of known substances not patentable unless enhanced efficacy (Novartis v. UoI, 2013)
  • Compulsory licensing (Section 84): Government can authorise third-party production if: (a) reasonable public need not met, (b) at affordable price, (c) patented invention not worked in India
    • Natco v. Bayer (2012) — first compulsory licence (Nexavar, cancer drug)
  • Pre-grant and post-grant opposition: Robust opposition mechanisms
  • Bolar exemption (Section 107A): Research/development exemption for generics

Copyright Framework (2012 Amendment):

  • Fair use provisions (Section 52)
  • Performers' rights — moral rights for actors, singers, musicians
  • Digital Rights Management (DRM) protection
  • Statutory licence for radio/TV broadcast
  • Synchronisation right — using music in films

Geographical Indications:

  • 400+ GI tags in India (e.g., Darjeeling Tea, Basmati Rice, Channapatna Toys, Banarasi Saree)
  • GI tag = community right — owned by producers/growers, not by individuals
  • Enforcement issues: Basmati (India vs. Pakistan), Turmeric (US patent revoked)

International Framework:

  • TRIPS Agreement (WTO, 1995) — minimum standards; Doha Declaration (2001) on public health
  • WIPO — administration, Patent Cooperation Treaty (PCT)
  • Madrid Protocol (trademark), Berne Convention (copyright)
  • Budapest Treaty (microorganisms), UPOV (plant varieties)

Key Facts

IP TypeIndian StatuteTRIPS Compliance
PatentPatents Act, 1970 (2005 final)Yes — product patents introduced 2005
CopyrightCopyright Act, 1957 (2012 amendment)Yes — WCT, WPPT compliant
TrademarkTrade Marks Act, 1999Yes — Madrid Protocol
GIGI Act, 1999Yes — Art. 22-24 TRIPS
SemiconductorSICLD Act, 2000Yes

PYQ Table

YearQuestionType
2023"Examine the role of IPR in promoting innovation and economic growth."Mains
2022"Discuss the TRIPS flexibilities available to India in the pharmaceutical sector."Mains
2021With reference to the Copyright Act, consider the following statements...Prelims
2020"How has the GI Act contributed to rural livelihoods in India?"Mains
2019Consider the following statements about the Patent Act amendments...Prelims
2017"Section 3(d) of the Indian Patents Act is a sensitive issue."Mains

Statement Elimination Guide

StatementTruth ValueWhy?
"India introduced product patents for pharmaceuticals in 2005"TruePatents (Amendment) Act 2005 — TRIPS compliance
"Copyright protection lasts for life + 50 years"FalseIt's life + 60 years in India (amended 1992, harmonised with Berne)
"GI tags can be owned by individuals"FalseGI tag is a community right — owned by authorised users/producers
"Compulsory licensing has been granted multiple times in India"FalseOnly one compulsory licence granted so far (Natco, 2012)
"Section 3(d) prevents evergreening of patents"TrueNovartis judgment upheld it in 2013

Current Affairs Hook

2023–24: India's patent filings crossed 90,000 annually (2023) — highest ever, but still low vs. China/US. The Basmati GI tag was granted to India (2023) after contesting Pakistan's claim in EU. IPR as a collateral for loans — new policy push. The Artificial Intelligence and IPR debate: can AI be named inventor? (India's 2023 patent office guidelines: NO). India's Position at WTO TRIPS Council — waiver on COVID-19 vaccines and diagnostics (extended to June 2024). The Copyright (Amendment) Rules, 2024 were notified. Saree GI tags controversy: Banarasi, Chanderi, Ilkal — authenticity enforcement issues.


Interlinkages

  • → TRIPS & WTO (GS-III): India's compliance timeline; Doha Declaration flexibilities
  • → Pharmaceuticals (GS-III): Jan Aushadhi, generic drug access, compulsory licensing
  • → Agriculture (GS-III): GI tags as rural marketing tools; PPV&FR for farmer rights
  • → S&T (GS-III): Innovation, R&D, patent filing incentives
  • → Competition Law (GS-III): Patent pools vs. anti-competitive practices
  • → Creative Economy (GS-I/III): Copyright in films, music, publishing

Common Mistakes

MistakeCorrection
"India introduced product patents in 1970"The 1970 Act only allowed process patents; product patents came in 2005
"Patent term is 20 years from the date of grant"20 years from the date of filing, not grant
"Copyright lasts for life + 50 years"India has life + 60 years
"All countries have the same IPR law"Each country has its own law; TRIPS sets minimum standards
"GI tag = trademark for a region"GI is different from trademark — it identifies origin, not just brand

Revision Snapshot

IPR in India
├── Patents (Patents Act 1970 → 2005 product patents)
│   ├── §3(d): No evergreening (Novartis)
│   └── Compulsory Licence (Natco 2012)
├── Copyright (1957, 2012 amend → life+60)
│   ├── Fair use (S.52)
│   └── DRM, Performers' rights
├── Trademark (1999, 10 yr renewable)
├── GI (1999, 400+ tags)
├── Designs, Plant Variety, Semiconductor
├── TRIPS (1995):
│   └── Doha Declaration (2001) on public health
└── Key Challenge: Low filings, enforcement, access vs. patents

Source Notes

  • Patents Act, 1970 (with amendments 1999, 2002, 2005)
  • Copyright Act, 1957 (amended 2012)
  • Trade Marks Act, 1999
  • GI of Goods Act, 1999
  • Novartis v. Union of India (2013) — 6 SCC 1
  • Natco Pharma v. Bayer (2012) — C.L. Application 1/2011
  • WTO — TRIPS Agreement and Doha Declaration
  • DIPP (now DPIIT) — National IPR Policy, 2016
  • WIPO — World Intellectual Property Indicators 2023